ROIV: Roivant Sciences Ltd. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 7,963.77
Enterprise Value ($M) 6,755.94
Book Value ($M) 5,580.04
Book Value / Share 7.67
Price / Book 1.43
NCAV ($M) 5,175.13
NCAV / Share 7.11
Price / NCAV 1.54

Profitability (mra)
Return on Invested Capital (ROIC) 0.81
Return on Assets (ROA) 0.66
Return on Equity (ROE) 0.73

Liquidity (mrq)
Quick Ratio 10.37
Current Ratio 10.43

Balance Sheet (mrq) ($M)
Current Assets 5,801.12
Assets 6,206.03
Liabilities 625.99
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-14 13G/A Viking Global Investors Lp 7.30 -22.01
11-12 13G Fmr Llc 6.64
11-12 13G/A Vanguard Group Inc 5.63 0.00
11-08 13G BlackRock, Inc. 5.70 0.00
04-02 13G/A Sumitomo Chemical Co., Ltd. 0.00 -100.00
03-07 13G/A QVT Financial LP 8.28 -40.72
02-14 13G/A Dexcel Pharma Technologies Ltd. 12.78 0.00
02-14 13G/A Ramaswamy Vivek 9.75 0.00
02-13 13G/A Sb Investment Advisers (uk) Ltd 9.10 -23.15

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-30 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-02-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-15 689,822 3,003,674 22.97
2025-01-14 1,210,493 4,854,810 24.93
2025-01-13 1,184,166 5,235,107 22.62
2025-01-10 893,963 5,807,350 15.39

(click for more detail)

Similar Companies
RIGL – Rigel Pharmaceuticals, Inc. RLMD – Relmada Therapeutics, Inc.
RLYB – Rallybio Corporation RPRX – Royalty Pharma plc
RPTX – Repare Therapeutics Inc.


Financial data and stock pages provided by
Fintel.io